S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)

ABSTRACT:

SUBMITTER: Kater A 

PROVIDER: S-EPMC10428463 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature